Susquehanna Fundamental Investments’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-18,524
| Closed | -$634K | – | 1665 |
|
|
2021
Q4 | $634K | Buy |
18,524
+5,509
| +42% | +$189K | 0.02% | 829 |
|
|
2021
Q3 | $231K | Sell |
13,015
-21,605
| -62% | -$383K | ﹤0.01% | 1492 |
|
|
2021
Q2 | $1.55M | Sell |
34,620
-13,000
| -27% | -$584K | 0.03% | 686 |
|
|
2021
Q1 | $1.23M | Buy |
47,620
+6,319
| +15% | +$164K | 0.02% | 807 |
|
|
2020
Q4 | $833K | Sell |
41,301
-99
| -0.2% | -$2K | 0.02% | 924 |
|
|
2020
Q3 | $809K | Buy |
41,400
+21,400
| +107% | +$418K | 0.02% | 720 |
|
|
2020
Q2 | $353K | Buy |
+20,000
| New | +$353K | 0.02% | 701 |
|